ID   UISO-CMN-1
AC   CVCL_ZL44
SY   CMN-1; University of Illinois Surgical Oncology-Congenital Melanocytic Naevus-1
DR   Wikidata; Q98133893
RX   PubMed=11828255;
RX   PubMed=12894234;
CC   Derived from site: In situ; Skin, dermis, nevus; UBERON=UBERON_1000010.
DI   NCIt; C3944; Congenital melanocytic nevus
DI   ORDO; Orphanet_626; Large congenital melanocytic nevus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
RX   PubMed=11828255; DOI=10.1097/00008390-200202000-00005;
RA   Mehta R.R., Bratescu L., Graves J.M., Shilkaitis A., Green A.D.,
RA   Mehta R.G., Das Gupta T.K.;
RT   "In vitro transformation of human congenital naevus to malignant
RT   melanoma.";
RL   Melanoma Res. 12:27-33(2002).
//
RX   PubMed=12894234; DOI=10.1038/sj.onc.1206741;
RA   Kichina J.V., Rauth S., Das Gupta T.K., Gudkov A.V.;
RT   "Melanoma cells can tolerate high levels of transcriptionally active
RT   endogenous p53 but are sensitive to retrovirus-transduced p53.";
RL   Oncogene 22:4911-4917(2003).
//